Rize Oncology Inc (RIZE.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 589 | 747 | 1,717 | 1,637 | 72 |
| Operating Income | -589 | -747 | -1,717 | -1,637 | -72 |
| Interest Expense | N/A | N/A | 0 | 0 | 1 |
| Other Income | 38 | 59 | 2 | 0 | 0 |
| Pre-tax Income | -551 | -688 | -1,715 | -1,638 | -73 |
| Net Income Continuous | -551 | -688 | -1,715 | -1,638 | -73 |
| Net Income | $-551 | $-688 | $-1,715 | $-1,638 | $-73 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.04 | -0.04 | 0.00 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.04 | N/A | N/A |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.04 | -0.04 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.04 | N/A | N/A |
| EBITDA(a) | $-589 | $-747 | $-1,715 | $-1,637 | $-72 |